Robbins Headache Clinic
For more than 25 years, headache sufferers in the Chicago area have found relief from their pain, thanks to our cutting-edge treatment based on the latest advancements in the field. Dr. Larry Robbins, M.D., and Nurse Practitioner Brooke Phenicie, NP-C, use a comprehensive combination of remedies for migraines, tension headaches and cluster headaches. To start your individualized treatment plan, call and make an appointment.
2610 Lake Cook Road, Suite 160 Riverwoods, IL 60015 847.374.9399
“NEW BOOK FROM DR. ROBBINS: ADVANCED HEADACHE THERAPY(ON AMAZON)
Treatment of headache at all ages. Hundreds of clinical tips/pearls. What to do when nothing works. Psychological conditions that often accompany severe headaches. Cutting edge medications and non-medicine approaches.” Hailed as “…the #1 resource for what to do for those with very difficult to treat headaches“….
Migraine is underdiagnosed and undertreated, said Dawn C. Buse, PhD, clinical professor of neurology at Albert Einstein College of Medicine, New York, and colleagues. Read more here.
Researchers, using data from more than 40,000 women, conclude that eating red meat is associated with an increased risk of breast cancer, but consuming poultry appears to link to a lower risk. Read more here.
A migraine plotline offers a teachable moment on an invisible disorder that disproportionately affects women. Read more here.
An intravenous formulation of a calcitonin gene–related peptide inhibitor monoclonal antibody showed efficacy for preventing chronic migraine headaches for 3 months in a dose-ranging, phase 3 trial with 1,072 patients. Read more here.
SEE GRAPH - Association between servings of caffeinated beverages compared to none and occurrence of migraine on the same day among 98 participants with episodic migraines followed for 6 weeks. Read more here.
Lenses that transition in sunlight to become sunglasses help protect eyes from dust, bugs, drying breezes and, most important of all, the damaging effects of ultraviolet light. Read more here.
Older men and women who stopped taking the drugs were at increased risk of heart attack and stroke. Read more here.
Higher perceived stress was associated with higher migraine frequency, but not chronic migraine, a new study found. Read more here.
Being more socially active in your 50s and 60s predicts a lower risk of developing dementia later on, finds a new UCL-led study published in PLOS Medicine. Read more here.
The more exposure that a person without migraine has to people with the disorder, the more likely he or she is to have potentially stigmatizing attitudes toward migraine, according to an analysis presented at the annual meeting of the American Headache Society. Read...
Anxiety Chronicles is a series from The Lily that examines the journeys different women have with anxiety. Read more here.
The bones may lose density as a person continues to age. After menopause, in particular, a person becomes susceptible to osteoporosis, a disease that can weaken the bones so much that they can break easily. Read more here.
In a pilot study, researchers explored art-based mindfulness activities that schools could use to reduce headaches, a common side effect of stress in adolescent girls. Read more here.
The article by Depre and colleagues demonstrated that the new migraine preventive erenumab may be safe for stable angina patients.
Girls who approach puberty at a more rapid rate than their peers may be at higher risk of migraine, according to new research. Read more here.
People with moderately high levels of riboflavin consumption from food – two to three times the recommended dietary allowance – had a significantly lower prevalence of a recent severe or migraine headache in a study of more than 3,600 younger U.S. adults. Read more...
Nine drug companies have received approval for the first generic versions of Lyrica (pregabalin), the U.S. Food and Drug Administration announced. Read more here.
Read more here.
Read more here.
Migraine patients fared as well when managed for a year by telemedicine as did patients managed by a 12-month series of routine office visits in a single-center, randomized trial with 40 patients Read more here.